SuperworthOnto Innovation ONTO
- Market cap
- $9.8B
- PE
- 74.7×
- 10y median 30.9×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 8.7×
- EV/EBIT
- 69.4×
- Revenue, 12 months
- $1.1B
- +8% on a year ago
- Net margin
- 11.8%
- Free cash flow yield
- 2.6%
Onto Innovation trades at 74.7× trailing earnings, pricier than 86% of the last ten years. Revenue was $1.1B over the last twelve months, up 8% on a year earlier with a 12% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $207.2M−19% | $218.9M−14% | $228.8M+15% | $242.3M+27% | $252.2M+22% | $263.9M+21% | $266.6M+17% | $253.6M+5% | $218.2M−14% | $266.9M+1% | $291.9M+10% | $343.1M+35% | |
| Cost of revenue | $100.3M−13% | $110.9M−4% | $110.6M+17% | $114.1M+27% | $115.8M+15% | $131.5M+19% | $123.4M+12% | $131.5M+15% | $107.6M−7% | $143.1M+9% | $145.6M+18% | $159.9M+22% |
| Gross profit | $106.9M−23% | $108M−21% | $118.3M+13% | $128.2M+28% | $136.4M+28% | $132.4M+23% | $143.2M+21% | $122.1M−5% | $110.6M−19% | $123.8M−7% | $146.4M+2% | $183.3M+50% |
| R&D | $26.1M−19% | $24M−14% | $26.6M−3% | $27M+0% | $28.3M+8% | $34.9M+45% | $28M+6% | $35.3M+31% | $32.5M+15% | $36.2M+4% | $35.1M+25% | $38.9M+10% |
| SG&A | $32.9M−2% | $42.4M+23% | $35.9M+3% | $38.6M+11% | $39.7M+21% | $41.9M−1% | $42.5M+18% | $39.9M+3% | $41.9M+6% | $52.7M+26% | $52.9M+24% | $57.4M+44% |
| $34M−43% | $28.2M−54% | $42.7M+47% | $48.8M+97% | $53.1M+56% | $42.5M+50% | $63.1M+48% | $32.2M−34% | $23.7M−55% | $13.9M−67% | $33.5M−47% | $63.5M+97% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $38.7M−35% | $33.8M−48% | $50.9M+58% | $57.3M+106% | $61M+58% | $51.3M+52% | $71.7M+41% | $39.7M−31% | $32M−48% | $19.5M−62% | $38.1M−47% | $68.5M+72% |
| $2.8M−63% | $3.5M | $4M+29% | $4.3M+121% | $8M+183% | $2.5M−30% | $7.6M+87% | $5.8M+35% | $3.8M−53% | $9M+267% | $4.3M−43% | $8.4M+44% | |
| Net income | $35.9M−31% | $30.3M−54% | $46.9M+61% | $52.9M+105% | $53.1M+48% | $48.8M+61% | $64.1M+37% | $33.9M−36% | $28.2M−47% | $10.5M−78% | $33.8M−47% | $60.1M+77% |
| $0.73−31% | $0.61−55% | $0.94+59% | $1.07+102% | $1.07+47% | $0.98+61% | $1.30+38% | $0.69−36% | $0.57−47% | $0.21−79% | $0.67−49% | $1.21+75% | |
| 49.4M−1% | 49.5M+1% | 49.6M+1% | 49.7M+1% | 49.7M+1% | 49.6M+0% | 49.4M−1% | 49M−1% | 49.1M−1% | 49.5M−0% | 50M+1% | 49.7M+1% |
Revenue: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY10: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY10: 6 months less the 3 months printed beside them.
R&D: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
SG&A: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Operating income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Income tax: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Net income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 16 periods, Q1 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY10: share-days: the 6-month average less the second quarter's. 10 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY11 to Q4 FY15: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Industrial - Machinery nearest Onto Innovation's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ONTOOnto Innovation | $9.8B | 74.7× | 30.9× | 8.7× | +8% | 11.8% | |
| DCIDONALDSON Co INC | $9.8B | 22.0× | 24.7× | 2.5× | +5% | 11.7% | |
| RRXRegal Rexnord | $9.9B | 30.5× | 23.8× | 1.6× | +4% | 5.4% | |
| AYIAcuity Inc. (de) | $9.5B | 21.1× | 19.6× | 2.1× | +10% | 10.3% | |
| TTCToro | $10B | 28.2× | 26.5× | 2.1× | +5% | 7.6% | |
| CRCrane | $10.6B | 32.0× | 33.1× | 4.1× | +16% | 13.0% | |
| PNRPENTAIR | $8.8B | 13.9× | 20.8× | 2.2× | −2% | 16.2% | |
| MOG-AMoog | $10.8B | 29.0× | 22.8× | 2.5× | +16% | 8.7% | |
| GGGGraco | $10.8B | 21.1× | 28.2× | 4.8× | +5% | 23.5% | |
| FLSFlowserve | $8.7B | 23.9× | 28.5× | 1.9× | −0% | 8.0% | |
| BWXTBWX Technologies | $11.7B | 33.0× | 28.2× | 3.3× | +23% | 10.1% | |
| Peer median | $9.9B | 26.0× | 25.6× | 2.4× | +5% | 10.2% |
Investors who own it
Investors we follow who held Onto Innovation at the end of Jun 30, 2026, from their 13F filings.
- Lee AinslieMaverick Capital0.0% of portfolionew
More on Onto Innovation
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Industrial - Machinery
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .